Vivimed Labs Limited ("Vivimed" or the Company), a niche Specialty Chemicals and Pharmaceuticals company, announced today that its FDF manufacturing facility located in Jeedimetla, near Hyderabad inspected in August 2017 by the Ukraine ministry of Health, has been approved and accredited with GMP Certification effective September 2017 and same has been renewed upto 04.02.2022 on 10.02.2021. Ukraine is a member Country of PICS, whose members include many European Countries.
The GMP approval extension also includes 5 new product registrations.
Commenting on the Approval / renewal, Ramesh Krishnamurthy, CEO of Vivimed Labs Ltd said, "Successful renewal of PICS GMP Certification enables Vivimed to scale up its branded product distribution in CIS Countries. Export thrust is key contributor to the growth strategy of Vivimed".
Shares of VIVIMED LABS LTD. was last trading in BSE at Rs.16.45 as compared to the previous close of Rs. 16.95. The total number of shares traded during the day was 85606 in over 252 trades.
The stock hit an intraday high of Rs. 17.4 and intraday low of 16.25. The net turnover during the day was Rs. 1416808.